MoneyWorks4Me

SMS Lifesciences - Quaterly Results

27 May 2024 Evaluate
The Sales for the quarter ended March 2024 of Rs. 863.74 millions rose by 31.76% from Rs. 655.52 millions.Net Profit for the quarter ended March 2024 zoomed to 140.40% from Rs. 24.68 millions to Rs. 59.33  millions.Operating profit for the quarter ended March 2024 rose to 130.92 millions as compared to 48.10 millions of corresponding quarter ended March 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 863.74 655.52 31.76 3000.02 3152.42 -4.83 3000.02 3152.42 -4.83
Other Income 22.79 22.86 -0.31 38.37 28.82 33.14 38.37 28.82 33.14
PBIDT 130.92 48.10 172.18 382.68 292.88 30.66 382.68 292.88 30.66
Interest 25.60 14.13 81.17 89.02 50.94 74.75 89.02 50.94 74.75
PBDT 105.32 57.49 83.20 293.66 265.46 10.62 293.66 265.46 10.62
Depreciation 26.24 21.17 23.95 102.54 81.73 25.46 102.54 81.73 25.46
PBT 79.08 36.32 117.73 191.12 183.73 4.02 191.12 183.73 4.02
TAX 19.75 11.64 69.67 60.47 51.55 17.30 60.47 51.55 17.30
Deferred Tax 12.22 22.64 -46.02 19.94 20.05 -0.55 19.94 20.05 -0.55
PAT 59.33 24.68 140.40 130.65 132.18 -1.16 130.65 132.18 -1.16
Equity 30.23 30.23 0.00 30.23 30.23 0.00 30.23 30.23 0.00
PBIDTM(%) 15.16 7.34 106.57 12.76 9.29 37.30 12.76 9.29 37.30
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..